Last update:

Diseases, Conditions, Syndromes news

Medical research

Synthetic peptide acts as molecular shield to prevent SARS-CoV-2 from infecting cells

A peptide synthesized by researchers at the University of São Paulo (USP) in Brazil protected human lung cells against infection by SARS-CoV-2 in the laboratory and eliminated the inflammation caused by the virus in mice ...

Diseases, Conditions, Syndromes

Viruses found hiding in lungs' immune cells long after initial illness

Doctors have long known that children who become seriously ill with certain respiratory viruses such as respiratory syncytial virus (RSV) are at elevated risk of developing asthma later in life. What they haven't known is ...

Medications

FDA approves Dupixent for chronic obstructive pulmonary disease

The U.S. Food and Drug Administration has approved Regeneron's Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic ...

Diseases, Conditions, Syndromes

Toll in Rwanda Marburg outbreak rises to 11

Five more people in Rwanda have died of the deadly Ebola-like Marburg disease, bringing the number of fatalities to 11, the health ministry said late Tuesday.

Diseases, Conditions, Syndromes

Mpox vaccination drive delayed in DR Congo

The mpox vaccination campaign in Democratic Republic of Congo has been pushed back, health authorities told AFP on Tuesday, with the exact start date unclear.

Diseases, Conditions, Syndromes

Creating a more accurate model of inflammatory bowel disease

A research team led by Junior Associate Professor Kazuo Takayama, from the Department of Cell Growth and Differentiation, recently constructed a new model of inflammatory bowel disease using iPS cells that enables more accurate ...

Diseases, Conditions, Syndromes

US investigating potential human-to-human bird flu transmission

Health authorities in the U.S. are studying seven people who developed influenza symptoms after being exposed to a Missouri bird flu patient, raising the possibility of the first human-to-human transmission of the infection.

Diseases, Conditions, Syndromes

Home-based phototherapy as effective as office-based for psoriasis

For plaque or guttate psoriasis, home-based narrowband ultraviolet B phototherapy is as effective as office-based phototherapy, according to a study published online Sept. 25 in JAMA Dermatology to coincide with the annual ...

Diseases, Conditions, Syndromes

Revealing global barriers to curative hep C treatment access

Almost 90% of the 57 million people living with hepatitis C live in low- and middle-income countries, but only half of these countries currently provide curative treatments at an accessible cost, according to a study by UNSW ...

Diseases, Conditions, Syndromes

Revealing the gut's crucial role in lung disease

Research led by the Centenary Institute, the University of Technology Sydney, and the Hunter Medical Research Institute suggests that the gut microbiome plays a pivotal role in the development of chronic obstructive pulmonary ...

Diseases, Conditions, Syndromes

Study finds no higher risk of miscarriage after COVID-19

LUMC research has shown that women who previously had a miscarriage due to COVID-19 are not at increased risk of having another miscarriage or a stillbirth. Nor are preventive drugs needed during the pregnancy.

Diseases, Conditions, Syndromes

FDA approves Eohilia for eosinophilic esophagitis

The U.S. Food and Drug Administration has approved Takeda's Eohilia (budesonide oral suspension) as the first and only oral treatment for eosinophilic esophagitis (EoE).

Medical research

Unveiling uremic toxins linked to itching in hemodialysis patients

Hemodialysis patients commonly experience itching on a daily basis, which is distributed throughout their bodies. A research team led by Dr. Yamamoto has found several uremic toxins that cause itching in hemodialysis patients. ...

Diseases, Conditions, Syndromes

Researchers investigate how the mpox virus infiltrates brain cells

A multidisciplinary team at the University of Alberta is seeking to understand how monkeypox (mpox) virus may be causing neurological symptoms in people affected by the global outbreak of mpox disease, declared by the World ...

Diseases, Conditions, Syndromes

Discovery provides new insight into severe liver disease

Primary sclerosing cholangitis (PSC) is a severe and chronic liver disease. It affects men more than women, and most people who are diagnosed with PSC are between 30 and 40 years old.

Diseases, Conditions, Syndromes

Immunocompromised population shown to react well to COVID-19 vaccine

First-year Hackensack Meridian School of Medicine (HMSOM) student Elizabeth Titova leveraged her background in phlebotomy and scientific research to publish a new clinical study around COVID-19 vaccination in Microbiology ...